文献速递老年综合评估衰弱、肌少症与跌倒认知障碍与谵妄

老年房颤患者的老年综合评估要素与口服抗凝药处方:SAGE-AF研究

Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE-AF.
PubMed 文献 · J Am Geriatr Soc · 2019-10-01

SAGE-AF队列基线横断面分析纳入1244例65岁以上、CHA2DS2-VASc评分≥2且无口服抗凝禁忌的房颤患者,采用六组分老年综合评估。结果显示认知障碍42%、衰弱14%、衰弱前期53%、社交隔离12%、抑郁症状29%,86%被处方口服抗凝药,且处方不随任何老年综合评估要素变化。

要点

  • 老年房颤患者中认知障碍和衰弱常见,但口服抗凝药处方未因这些因素而减少。
  • 86%的队列被处方口服抗凝药,各老年综合评估要素与处方均无显著关联。
  • 研究者提示处方者可能未识别或有意忽略这些常被引为不处方理由的因素。

核心结论

  • 老年综合评估损伤在房颤队列中常见,但口服抗凝药治疗不因损伤状态而异。

研究设计与样本

  • SAGE-AF前瞻性队列研究基线数据的横断面分析,2016至2018年从马萨诸塞州和佐治亚州的心脏科、电生理科和初级保健诊所多中心招募。
  • 纳入1244例65岁及以上、CHA2DS2-VASc评分≥2且无口服抗凝禁忌的房颤患者,平均年龄76岁,49%女性,85%白人。

主要发现

  • 认知障碍占42%,衰弱占14%,衰弱前期占53%,社交隔离占12%,抑郁症状占29%。
  • 86%的队列被处方口服抗凝药。

关键数值与推荐

  • 六组分老年综合评估包括衰弱、认知功能、社会支持、抑郁症状、视觉和听觉的验证量表。
  • 口服抗凝药使用从病历中提取。

临床怎么用

  • 在老年房颤患者中,认知障碍和衰弱普遍存在,但不应仅凭这些因素常规拒绝口服抗凝药处方。
  • 临床处方者需系统识别老年综合评估要素,避免因未识别或忽略而影响抗凝决策。

局限性

  • 横断面分析无法推断因果关系。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Oral anticoagulants are the cornerstone of stroke prevention in high-risk patients with atrial fibrillation (AF). Geriatric elements, such as cognitive impairment and frailty, commonly occur in these patients and are often cited as reasons for not prescribing oral anticoagulants. We sought to systematically assess geriatric impairments in patients with AF and determine whether they were associated with oral anticoagulant prescribing. DESIGN: Cross-sectional analysis of baseline data from the ongoing Systematic Assessment of Geriatric Elements in Atrial Fibrillation (SAGE-AF) prospective cohort study. SETTING: Multicenter study with site locations in Massachusetts and Georgia that recruited participants from cardiology, electrophysiology, and primary care clinics from 2016 to 2018. PARTICIPANTS: Participants with AF age 65 years or older, CHA2 DS2 -VASc (congestive heart failure; hypertension; aged ≥75 y [doubled]; diabetes mellitus; prior stroke, transient ischemic attack, or thromboembolism [doubled]; vascular disease; age 65-74; female sex) score of 2 or higher, and no oral anticoagulant contraindications (n = 1244). MEASUREMENTS: A six-component geriatric assessment included validated measures of frailty, cognitive function, social support, depressive symptoms, vision, and hearing. Oral anticoagulant use was abstracted from the medical record. RESULTS: A total of 1244 participants (mean age = 76 y; 49% female; 85% white) were enrolled; 42% were cognitively impaired, 14% frail, 53% pre-frail, 12% socially isolated, and 29% had depressive symptoms. Oral anticoagulants were prescribed to 86% of the cohort. Oral anticoagulant prescribing did not vary according to any of the geriatric elements (adjusted odds ratios [ORs] for oral anticoagulant prescribing and cognitive impairment: OR = .75; 95% confidence interval [CI] = .51-1.09; frail OR = .69; 95% CI = .35-1.36; social isolation OR = .90; 95% CI = .52-1.54; depression OR = .79; 95% CI = .49-1.27; visual impairment OR = .98; 95% CI = .65-1.48; and hearing impairment OR = 1.05; 95% CI = .71-1.54). CONCLUSION: Geriatric impairments, particularly cognitive impairment and frailty, were common in our cohort, but treatment with oral anticoagulants did not differ by impairment status. These geriatric impairments are commonly cited as reasons for not prescribing oral anticoagulants, suggesting that prescribers may either be unaware or deliberately ignoring the presence of these factors in clinical settings. J Am Geriatr Soc 68:147-154, 2019.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Saczynski JS, Sanghai SR, Kiefe CI, et al. Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE-AF. J Am Geriatr Soc. 2019. PMID: 31574165. doi:10.1111/jgs.16178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。